Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Crott

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Pharmacoeconomics|February 6, 1997
Pricing and reimbursement of pharmaceuticals in BelgiumL Annemans, R Crott, H De Clercq, et al.
BMC Cancer|June 1, 2023
Treatment of supraglottic squamous cell carcinoma with advanced technologies: observational prospective evaluation of oncological outcomes, functional outcomes, quality of life and cost-effectiveness (SUPRA-QoL)S Hassid, B Krug, S Deheneffe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)V C G Tjan-Heijnen, S Caleo, P E Postmus, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Pharmacoeconomics|February 6, 1997
Pricing and reimbursement of pharmaceuticals in BelgiumL Annemans, R Crott, H De Clercq, et al.
BMC Cancer|June 1, 2023
Treatment of supraglottic squamous cell carcinoma with advanced technologies: observational prospective evaluation of oncological outcomes, functional outcomes, quality of life and cost-effectiveness (SUPRA-QoL)S Hassid, B Krug, S Deheneffe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)V C G Tjan-Heijnen, S Caleo, P E Postmus, et al.
Pageof 2